<TABLE> <S> <C>


<ARTICLE>                     5
<CIK>                         1036968
<NAME>                        Vaxgen, Inc.
<MULTIPLIER>                                   1,000

<S>                             <C>
<PERIOD-TYPE>                   9-Mos
<FISCAL-YEAR-END>                              Dec-31-2000
<PERIOD-START>                                 Jan-01-2000
<PERIOD-END>                                   Sep-30-2000
<CASH>                                         12,211
<SECURITIES>                                   42,994
<RECEIVABLES>                                  0
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               57,556
<PP&E>                                         3,046
<DEPRECIATION>                                 0
<TOTAL-ASSETS>                                 60,826
<CURRENT-LIABILITIES>                          4,444
<BONDS>                                        0
                          0
                                    0
<COMMON>                                       136
<OTHER-SE>                                     110,294
<TOTAL-LIABILITY-AND-EQUITY>                   60,826
<SALES>                                        0
<TOTAL-REVENUES>                               200
<CGS>                                          0
<TOTAL-COSTS>                                  0
<OTHER-EXPENSES>                               19,640
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             15
<INCOME-PRETAX>                                (16,443)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            0
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (16,443)
<EPS-BASIC>                                    (1.21)
<EPS-DILUTED>                                  (1.21)



</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission